Global Opioid Use Disorder OUD Market Report 2024

Opioid Use Disorder (OUD) Global Market Report 2024 – By Drug Type (Buprenorphine, Naltrexone, Methadone), By Route of Administration (Oral, Parenteral), By Age Group (19 To 40, 41 To 60, 61 And Over), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

Opioid Use Disorder (OUD) Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Opioid Use Disorder (OUD) Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Opioid Use Disorder (Oud) Market Definition And Segments

Opioid use disorder (OUD) is a chronic brain disease resulting from prolonged use of opioids, including both prescription painkillers and illegal opioids. Opioid use disorder can develop due to genetic, environmental, and behavioral factors.

The main types of drugs for opioid use disorder (OUD) are buprenorphine, naltrexone, and methadone. Buprenorphine refers to a medication that belongs to the class of drugs known as opioids. Buprenorphine is used in the treatment of opioid use disorder (OUD) to reduce cravings and withdrawal symptoms associated with opioid dependence. They are administered through oral and parenteral routes for various age groups including 19 to 40, 41 to 60, 61 and over. It is distributed by hospital pharmacies, retail pharmacies and stores, and online pharmacies.

The opioid use disorder (OUD) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

The opioid use disorder (OUD) market size has grown rapidly in recent years. It will grow from $3.53 billion in 2023 to $3.93 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increased prescription rates, pain management practices, drug marketing, stigmatization of addiction.

The opioid use disorder (OUD) market size is expected to see rapid growth in the next few years. It will grow to $6.04 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to regulatory interventions, focus on alternative pain management, expansion of treatment access, public health initiatives, . Major trends in the forecast period include technological innovations in treatment, individualized treatment approaches, integrated care models, community-based support programs, early intervention and prevention.

Growing Number Of Opioid Addiction Cases

The growing number of opioid addiction cases is expected to propel the growth of the opioid use disorder (OUD) market going forward. Opioid addiction refers to a medical condition characterized by compulsive and chronic opioid use that has harmful effects on the body. Opioids can produce a sense of euphoria and pain relief, whose continued usage can lead to the development of tolerance, where higher doses are needed to achieve the same effect, which may lead to opioid use disorder. For instance, in May 2022, according to the Centers for Disease Control and Prevention, a US-based government agency, opioid overdose deaths in the USA increased by 15% from 70,029 in 2020 to 80,816 in 2021. Therefore, the growing number of opioid addiction cases drives the growth of the opioid use disorder (OUD) market.

Rise In The Prevalence Of Chronic Disease

Rise in the prevalence of chronic disease is expected to propel the growth of the opioid use disorder (OUD) market going forward. Chronic diseases are problems that last a year or longer, necessitating continuing medical care, restricting everyday activities, or both. Many chronic conditions, such as severe pain associated with cancer, arthritis, or other long-term illnesses, often necessitate the use of opioid medications for effective pain management. For instance, in January 2023, according to the National Centre for Biotechnology Information (NCBI), a US-based National Library of Medicine, it was projected that by the year 2050, the number of individuals aged 50 years and older who have at least one chronic illness will surge by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Therefore, the rise in the prevalence of chronic disease drives the growth of the opioid use disorder (OUD) market.

Major companies operating in the opioid use disorder (OUD) market report are Pfizer Inc., Novartis AG, AstraZeneca plc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Knight Therapeutics Inc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Insys Therapeutics Inc., MediciNova Inc., Cara Therapeutics Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.,

FDA Approval Of Brixadi Marks A Milestone In Opioid Use Disorder (OUD) Market Through Innovative Treatment Options

Product innovation is a key trend gaining popularity in the opioid use disorder (OUD) market. Major companies operating in the opioid use disorder (OUD) market are developing innovative products to sustain their position in the market. For instance, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, approved Brixadi (buprenorphine) extended-release injection to treat moderate to severe opioid use disorder (OUD). Brixadi is available in two dosage forms a weekly injection for patients who began treatment with a single dose of a transmucosal buprenorphine product or who are currently taking the medication and a monthly version for those who are already receiving the medication.

Harm Reduction Therapeutics And Catalent Join Forces To Enhance Access To Opioid Overdose Treatment In The Opioid Use Disorder (OUD) Market

Major companies operating in the opioid use disorder (OUD) market are focused on forming strategic alliances to strengthen their position in the market. Strategic alliances can take various forms and are aimed at achieving mutual benefits and strengthening the position of the companies involved. For instance, in March 2023, Harm Reduction Therapeutics, a US-based non-profit pharmaceutical company, entered a partnership with Catalent, Inc., a US-based company in developing and delivering better treatments to patients around the world. Under this agreement, Catalent, Inc. will manufacture RiVive (3.0 mg), a naloxone nasal spray for harm reduction therapy for emergency treatment of known or suspected opioid overdose. The opioid epidemic is an ongoing national tragedy, and for OTC naloxone to address this unmet needed a manufacturing partner with the capability and bandwidth to help make naloxone much more widely and easily accessible to save lives that will otherwise be lost to opioid overdose.

Indivior Enhances Addiction Treatment Portfolio With $145 Million Acquisition Of Opiant Pharmaceuticals

In March 2023, Indivior PLC, a US-based pharmaceutical company, acquired Opiant Pharmaceuticals Inc. for $145 million. The acquisition is expected to help Indivior plc strengthen and extend its product offering for addiction treatment. Opiant Pharmaceuticals Inc. is a US-based pharmaceutical company that focuses on developing drugs for treating opioid overdose, acute cannabinoid overdose, and opioid use disorder.

North America was the largest region in the opioid use disorder (OUD) market in 2023. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the opioid use disorder (oud) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The opioid use disorder (OUD) market consists of sales of bunavail, sublocade, suboxone, and zubsolv. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The opioid use disorder (OUD) research report is one of a series of new reports from The Business Research Company that provides opioid use disorder (OUD) market statistics, including the opioid use disorder (OUD) industry's global market size, regional shares, competitors with opioid use disorder (OUD) market share, detailed opioid use disorder (OUD) market segments, market trends and opportunities, and any further data you may need to thrive in the opioid use disorder (OUD) industry. This opioid use disorder (OUD) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Opioid Use Disorder (OUD) Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $3.93 billion
Revenue Forecast In 2033 $6.04 billion
Growth Rate CAGR of 11.3% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drug Type: Buprenorphine, Naltrexone, Methadone
2) By Route of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Novartis AG; AstraZeneca plc.; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Chiesi Pharmaceuticals S.p.A.; Hikma Pharmaceuticals Plc.; Mallinckrodt Pharmaceuticals; Indivior Plc.; Knight Therapeutics Inc.; Purdue Pharma L.P; Alkermes Inc.; Collegium Pharmaceutical Inc.; Vanda Pharmaceuticals Inc.; Camurus AB; Tris Pharma Inc.; Mylan NV.; Orexo US Inc.; Zogenix Inc.; Rhodes Pharmaceuticals L.P.; Omeros Corporation; Braeburn Pharmaceuticals Inc.; Adapt Pharma Inc.; Titan Pharmaceuticals Inc.; BioDelivery Sciences International Inc.; Insys Therapeutics Inc.; MediciNova Inc.; Cara Therapeutics Inc.; AcelRx Pharmaceuticals Inc.; KemPharm Inc.;
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Opioid Use Disorder (OUD) Market Characteristics

    3. Opioid Use Disorder (OUD) Market Trends And Strategies

    4. Opioid Use Disorder (OUD) Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Opioid Use Disorder (OUD) Market Size and Growth

    5.1. Global Opioid Use Disorder (OUD) Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Opioid Use Disorder (OUD) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Opioid Use Disorder (OUD) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Opioid Use Disorder (OUD) Market Segmentation

    6.1. Global Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Buprenorphine

    Naltrexone

    Methadone

    6.2. Global Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Parenteral

    6.3. Global Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19 To 40

    41 To 60

    61 And Over

    6.4. Global Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies And Stores

    Online Pharmacies

    7. Opioid Use Disorder (OUD) Market Regional And Country Analysis

    7.1. Global Opioid Use Disorder (OUD) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Opioid Use Disorder (OUD) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Opioid Use Disorder (OUD) Market

    8.1. Asia-Pacific Opioid Use Disorder (OUD) Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Opioid Use Disorder (OUD) Market

    9.1. China Opioid Use Disorder (OUD) Market Overview

    9.2. China Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Opioid Use Disorder (OUD) Market

    10.1. India Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Opioid Use Disorder (OUD) Market

    11.1. Japan Opioid Use Disorder (OUD) Market Overview

    11.2. Japan Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Opioid Use Disorder (OUD) Market

    12.1. Australia Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Opioid Use Disorder (OUD) Market

    13.1. Indonesia Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Opioid Use Disorder (OUD) Market

    14.1. South Korea Opioid Use Disorder (OUD) Market Overview

    14.2. South Korea Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Opioid Use Disorder (OUD) Market

    15.1. Western Europe Opioid Use Disorder (OUD) Market Overview

    15.2. Western Europe Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Opioid Use Disorder (OUD) Market

    16.1. UK Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Opioid Use Disorder (OUD) Market

    17.1. Germany Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Opioid Use Disorder (OUD) Market

    18.5. France Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Opioid Use Disorder (OUD) Market

    19.9. Italy Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Opioid Use Disorder (OUD) Market

    20.13. Spain Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Opioid Use Disorder (OUD) Market

    21.1. Eastern Europe Opioid Use Disorder (OUD) Market Overview

    21.2. Eastern Europe Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Opioid Use Disorder (OUD) Market

    22.1. Russia Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Opioid Use Disorder (OUD) Market

    23.1. North America Opioid Use Disorder (OUD) Market Overview

    23.2. North America Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Opioid Use Disorder (OUD) Market

    24.1. USA Opioid Use Disorder (OUD) Market Overview

    24.2. USA Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Opioid Use Disorder (OUD) Market

    25.1. Canada Opioid Use Disorder (OUD) Market Overview

    25.2. Canada Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Opioid Use Disorder (OUD) Market

    26.1. South America Opioid Use Disorder (OUD) Market Overview

    26.2. South America Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Opioid Use Disorder (OUD) Market

    27.1. Brazil Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Opioid Use Disorder (OUD) Market

    28.1. Middle East Opioid Use Disorder (OUD) Market Overview

    28.2. Middle East Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Opioid Use Disorder (OUD) Market

    29.1. Africa Opioid Use Disorder (OUD) Market Overview

    29.2. Africa Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Opioid Use Disorder (OUD) Market Competitive Landscape And Company Profiles

    30.1. Opioid Use Disorder (OUD) Market Competitive Landscape

    30.2. Opioid Use Disorder (OUD) Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Novartis AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. AstraZeneca plc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Viatris Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Teva Pharmaceutical Industries Ltd.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Opioid Use Disorder (OUD) Market Other Major And Innovative Companies

    31.1. Chiesi Pharmaceuticals S.p.A.

    31.2. Hikma Pharmaceuticals Plc.

    31.3. Mallinckrodt Pharmaceuticals

    31.4. Indivior Plc.

    31.5. Knight Therapeutics Inc.

    31.6. Purdue Pharma L.P

    31.7. Alkermes Inc.

    31.8. Collegium Pharmaceutical Inc.

    31.9. Vanda Pharmaceuticals Inc.

    31.10. Camurus AB

    31.11. Tris Pharma Inc.

    31.12. Mylan NV.

    31.13. Orexo US Inc.

    31.14. Zogenix Inc.

    31.15. Rhodes Pharmaceuticals L.P.

    32. Global Opioid Use Disorder (OUD) Market Competitive Benchmarking

    33. Global Opioid Use Disorder (OUD) Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Opioid Use Disorder (OUD) Market

    35. Opioid Use Disorder (OUD) Market Future Outlook and Potential Analysis

    35.1 Opioid Use Disorder (OUD) Market In 2028 - Countries Offering Most New Opportunities

    35.2 Opioid Use Disorder (OUD) Market In 2028 - Segments Offering Most New Opportunities

    35.3 Opioid Use Disorder (OUD) Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Opioid Use Disorder (OUD) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Opioid Use Disorder (OUD) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Novartis AG Financial Performance
  • Table 77: AstraZeneca plc. Financial Performance
  • Table 78: Viatris Inc. Financial Performance
  • Table 79: Teva Pharmaceutical Industries Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Opioid Use Disorder (OUD) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Opioid Use Disorder (OUD) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Novartis AG Financial Performance
  • Figure 77: AstraZeneca plc. Financial Performance
  • Figure 78: Viatris Inc. Financial Performance
  • Figure 79: Teva Pharmaceutical Industries Ltd. Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Used Truck Global Market Report 2024 – By Type (Light-Duty Truck, Medium-Duty Truck, Heavy-Duty Truck), By Fuel Type (Gasoline, Electric, Diesel), By Sales Channel (Franchised Dealer, Independent Dealer, Peer-To-Peer), By End-Use (Construction, Oil And Gas, Mining, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Used Cars Global Market Report 2024 – By Vehicle Type (Hatchback, Sedan, SUV), By Fuel Type (Petrol, Diesel, Hybrid/Electric), By Sales Channel (Peer-To-Peer, Franchised Dealers, Independent Dealers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Non-Opioid Pain Patch Global Market Report 2024 – By Patch (Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ketoprofen Patches, Other Patches), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By Indication (Musculoskeletal Pain, Neuropathic Pain) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Analgesics Global Market Report 2024 – By Type (Non-opioids, Opioids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores), By Application (Internal Analgesics, External Analgesics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Antiemetics And Antinauseants Global Market Report 2024 – By Drug (Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types), By Application (Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types), By End Users (Hospital, Medical Center, Clinic, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Substance Abuse And Addiction Treatment Global Market Report 2024 – By Abuse Type (Alcohol Dependence, Tobacco or Nicotine Addiction, Other Abuse Types), By Treatment (Alcohol Addiction Treatment, Tobacco or Nicotine Addiction Treatment, Opioid Addiction Treatment, Other Treatments), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pain Management Drugs Global Market Report 2024 – By Drug Class (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle sprain/strain, Bone fracture, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Oral Thin Films Global Market Report 2024 – By Type (Sublingual Film, Fast Dissolving Dental/Buccal Film), By Disease Indication (Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Other Disease Indication), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the opioid use disorder (OUD) market?

Opioid use disorder (OUD) is a chronic brain disease resulting from prolonged use of opioids, including both prescription painkillers and illegal opioids. Opioid use disorder can develop due to genetic, environmental, and behavioral factors. For further insights on the opioid use disorder (OUD) market, request a sample here

How will the opioid use disorder (OUD) market drivers and restraints affect the opioid use disorder (OUD) market dynamics? What forces will shape the opioid use disorder (OUD) industry going forward?

The opioid use disorder (OUD) market major growth driver - The Growing Number Of Opioid Addiction Cases. For further insights on the opioid use disorder (OUD) market, request a sample here

What is the forecast market size or the forecast market value of the opioid use disorder (OUD) market?

The opioid use disorder (OUD) market size has grown rapidly in recent years. It will grow from $3.53 billion in 2023 to $3.93 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increased prescription rates, pain management practices, drug marketing, stigmatization of addiction. The opioid use disorder (OUD) market size is expected to see rapid growth in the next few years. It will grow to $6.04 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to regulatory interventions, focus on alternative pain management, expansion of treatment access, public health initiatives, . Major trends in the forecast period include technological innovations in treatment, individualized treatment approaches, integrated care models, community-based support programs, early intervention and prevention. For further insights on the opioid use disorder (OUD) market, request a sample here

How is the opioid use disorder (OUD) market segmented?

The opioid use disorder (OUD) market is segmented
1) By Drug Type: Buprenorphine, Naltrexone, Methadone
2) By Route of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online PharmaciesFor further insights on the opioid use disorder (OUD) market, request a sample here

Which region has the largest share of the opioid use disorder (OUD) market? What are the other regions covered in the report?

North America was the largest region in the opioid use disorder (OUD) market in 2023. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the opioid use disorder (OUD) market, request a sample here.

Who are the major players in the opioid use disorder (OUD) market?

Major companies operating in the opioid use disorder (OUD) market report are Pfizer Inc., Novartis AG, AstraZeneca plc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Knight Therapeutics Inc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Insys Therapeutics Inc., MediciNova Inc., Cara Therapeutics Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc., For further insights on the opioid use disorder (OUD) market, request a sample here.

What are the key trends in the opioid use disorder (OUD) market?

Major trend in the opioid use disorder (OUD) market - FDA Approval Of Brixadi Marks A Milestone In Opioid Use Disorder (OUD) Market Through Innovative Treatment Options. For further insights on the opioid use disorder (OUD) market, request a sample here.

What are the major opportunities in the opioid use disorder (OUD) market? What are the strategies for the opioid use disorder (OUD) market?

For detailed insights on the major opportunities and strategies in the opioid use disorder (OUD) market, request a sample here.

How does the opioid use disorder (OUD) market relate to the overall economy and other similar markets?

For detailed insights on opioid use disorder (OUD) market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the opioid use disorder (OUD) industry?

For detailed insights on the mergers and acquisitions in the opioid use disorder (OUD) industry, request a sample here.

What are the key dynamics influencing the opioid use disorder (OUD) market growth? SWOT analysis of the opioid use disorder (OUD) market.

For detailed insights on the key dynamics influencing the opioid use disorder (OUD) market growth and SWOT analysis of the opioid use disorder (OUD) industry, request a sample here.